August 20, 2018 – By Jeanette Garcia
Bvf Inc decreased its stake in Chemocentryx Inc (CCXI) by 5.09% based on its latest 2018Q1 regulatory filing with the SEC. Bvf Inc sold 386,100 shares as the company’s stock rose 32.26% while stock markets declined. The hedge fund held 7.20M shares of the health care company at the end of 2018Q1, valued at $97.94M, down from 7.59 million at the end of the previous reported quarter. Bvf Inc who had been investing in Chemocentryx Inc for a number of months, seems to be less bullish one the $555.68M market cap company. The stock increased 0.73% or $0.08 during the last trading session, reaching $11.03. About 163,923 shares traded. ChemoCentryx, Inc. (NASDAQ:CCXI) has risen 83.50% since August 20, 2017 and is uptrending. It has outperformed by 70.93% the S&P500. Some Historical CCXI News: 10/05/2018 – Invus Public Equities Advisors Exits Position in ChemoCentryx; 03/04/2018 – ChemoCentryx Presenting at Conference Apr 9; 09/05/2018 – ChemoCentryx 1Q Loss/Shr 19c; 31/03/2018 – ChemoCentryx Conference Set By H.C. Wainwright for Apr. 8-10; 09/03/2018 – ChemoCentryx 4Q Rev $56.3M; 20/04/2018 – DJ Chemocentryx Inc, Inst Holders, 1Q 2018 (CCXI); 09/03/2018 – CHEMOCENTRYX SEES 2018 CASH & INVESTMENTS USE $65M-$75M; 09/03/2018 – CCXI PLANS TO START DEVT AVACOPAN IN HIDRADENITIS SUPPURATIVA; 09/03/2018 – ChemoCentryx Expects to Utilize Between $65M-$75M Cash and Investments in FY18; 09/05/2018 – CHEMOCENTRYX INC – EXPECTS TO UTILIZE CASH AND INVESTMENTS BETWEEN $65 MLN AND $75 MLN FOR TWELVE MONTHS ENDING DECEMBER 31, 2018
Cullen Capital Management Llc increased its stake in Companhia De Saneamento Basico (SBS) by 68.41% based on its latest 2018Q1 regulatory filing with the SEC. Cullen Capital Management Llc bought 367,550 shares as the company’s stock declined 36.25% with the market. The institutional investor held 904,800 shares of the water supply company at the end of 2018Q1, valued at $9.58 million, up from 537,250 at the end of the previous reported quarter. Cullen Capital Management Llc who had been investing in Companhia De Saneamento Basico for a number of months, seems to be bullish on the $4.46 billion market cap company. The stock decreased 2.29% or $0.15 during the last trading session, reaching $6.41. About 1.54 million shares traded. Companhia de Saneamento BÃ¡sico do Estado de SÃ£o Paulo – SABESP (NYSE:SBS) has declined 16.78% since August 20, 2017 and is downtrending. It has underperformed by 29.35% the S&P500. Some Historical SBS News: 27/03/2018 – Brazil regulator proposes 4.8 pct tariff hike for Sabesp sewage co; 10/05/2018 – SABESP 1Q ADJ EBITDA R$1.40B, EST. R$1.54B; 16/03/2018 – Consolidated Research: 2018 Summary Expectations for MacroGenics, Radware, Core-Mark Holding, Companhia de saneamento Basico Do; 14/05/2018 – BRAZIL’S SABESP SAYS BOARD ELECTED KARLA TRINDADE AS NEW CHIEF EXECUTIVE OFFICER TO REPLACE JERSON KELMAN – FILING; 11/03/2018 – SABESP: CORPORATE REORGANIZATION OF SABESP; 11/03/2018 SABESP: GROUP INTERESTED IN BUYING SHRS TO BE ISSUED BY HOLDCO; 10/05/2018 – SABESP 1Q NET INCOME R$580.4M, EST. R$622.0M; 28/03/2018 – SABESP: Board Has Decided on Payment of Interest on Own Capital for 2017; 27/03/2018 – BRAZIL WATER AND SEWAGE COMPANY SABESP SAYS SAO PAULO STATE SANITATION REGULATOR PROPOSES IN PRELIMINARY TECHNICAL NOTE 4.8 PCT TARIFF HIKE IN FINAL STAGE OF TARIFF REVIEW; 10/05/2018 – COMPANHIA DE SANEAMENTO BASICO DO ESTADO DE SAO PAULO – SABESP- QTRLY NET INCOME OF R$ 580.4 MLN, COMPARED TO A NET INCOME OF R$ 674.4 MLN IN 1Q17
Investors sentiment decreased to 1 in Q1 2018. Its down 0.30, from 1.3 in 2017Q4. It turned negative, as 10 investors sold CCXI shares while 36 reduced holdings. 24 funds opened positions while 22 raised stakes. 24.22 million shares or 3.03% more from 23.51 million shares in 2017Q4 were reported. Landscape Capital holds 0.02% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 24,145 shares. Invesco Ltd stated it has 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). Citigroup stated it has 3,315 shares or 0% of all its holdings. 10,828 were accumulated by Savings Bank Of Montreal Can. California Employees Retirement Sys owns 62,800 shares or 0% of their US portfolio. Alliancebernstein Lp stated it has 40,100 shares. Smith Asset Group Ltd Partnership has invested 0.01% in ChemoCentryx, Inc. (NASDAQ:CCXI). Wasatch Advsr holds 2.38 million shares or 0.42% of its portfolio. Deutsche Bank & Trust Ag holds 0% in ChemoCentryx, Inc. (NASDAQ:CCXI) or 27,008 shares. J Goldman & LP invested in 0.02% or 39,000 shares. Arrowstreet Capital Partnership holds 0% or 34,216 shares in its portfolio. Wells Fargo Mn owns 52,971 shares for 0% of their portfolio. 25,200 were accumulated by Ellington Mgmt Gp Limited Liability Company. The Colorado-based Alps Advisors has invested 0% in ChemoCentryx, Inc. (NASDAQ:CCXI). 22,960 were reported by Piermont Cap Management Inc.
More notable recent ChemoCentryx, Inc. (NASDAQ:CCXI) news were published by: Nasdaq.com which released: “ChemoCentryx Reports Second Quarter 2018 Financial Results and Recent Highlights” on August 09, 2018, also Benzinga.com with their article: “45 Stocks Moving In Tuesday’s Mid-Day Session” published on August 14, 2018, Nasdaq.com published: “ChemoCentryx to Hold Second Quarter 2018 Financial Results Conference Call on Thursday, August 9, 2018” on August 02, 2018. More interesting news about ChemoCentryx, Inc. (NASDAQ:CCXI) were released by: Seekingalpha.com and their article: “ChemoCentryx 2018 Q2 – Results – Earnings Call Slides” published on August 10, 2018 as well as Benzinga.com‘s news article titled: “58 Biggest Movers From Yesterday” with publication date: August 15, 2018.
Bvf Inc, which manages about $999.89M and $986.48 million US Long portfolio, upped its stake in Forward Pharma A/S by 1.30 million shares to 4.76M shares, valued at $10.32 million in 2018Q1, according to the filing. It also increased its holding in Corvus Pharmaceuticals Inc by 1.49 million shares in the quarter, for a total of 1.95 million shares, and has risen its stake in Immune Design Corp (NASDAQ:IMDZ).
Since May 1, 2018, it had 0 insider purchases, and 12 sales for $7.89 million activity. KANAYA SUSAN M sold $15,709 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) on Wednesday, May 2. $152,028 worth of ChemoCentryx, Inc. (NASDAQ:CCXI) was sold by Schall Thomas J..
Among 7 analysts covering ChemoCentryx (NASDAQ:CCXI), 4 have Buy rating, 1 Sell and 2 Hold. Therefore 57% are positive. ChemoCentryx had 10 analyst reports since September 3, 2015 according to SRatingsIntel. Zacks downgraded the shares of CCXI in report on Monday, September 21 to “Sell” rating. The company was maintained on Tuesday, August 8 by Cowen & Co. The stock has “Buy” rating by JMP Securities on Thursday, August 10. The firm earned “Mkt Outperform” rating on Tuesday, February 21 by JMP Securities. On Tuesday, March 13 the stock rating was maintained by JP Morgan with “Overweight”. The firm has “Neutral” rating by JP Morgan given on Tuesday, August 14. The firm has “Sell” rating given on Thursday, September 3 by Zacks.
Analysts await ChemoCentryx, Inc. (NASDAQ:CCXI) to report earnings on November, 6. They expect $-0.26 earnings per share, down 100.00% or $0.13 from last year’s $-0.13 per share. After $-0.14 actual earnings per share reported by ChemoCentryx, Inc. for the previous quarter, Wall Street now forecasts 85.71% negative EPS growth.
Another recent and important Companhia de Saneamento BÃ¡sico do Estado de SÃ£o Paulo – SABESP (NYSE:SBS) news was published by Seekingalpha.com which published an article titled: “Companhia de Saneamento Basico do Estado de Sao Paulo-SABESP (SBS) CEO Karla Bertocco Trindade on Q2 …” on August 15, 2018.
Among 6 analysts covering Basic Sanitation Company of the State of Sao Paulo (NYSE:SBS), 2 have Buy rating, 1 Sell and 3 Hold. Therefore 33% are positive. Basic Sanitation Company of the State of Sao Paulo had 9 analyst reports since February 21, 2017 according to SRatingsIntel. The firm has “Buy” rating given on Monday, November 27 by J.P. Morgan. The firm has “Sell” rating given on Monday, August 14 by Citigroup. The firm earned “Sell” rating on Thursday, April 20 by Citigroup. The stock has “Buy” rating by HSBC on Wednesday, November 22. The firm earned “Overweight” rating on Monday, November 27 by JP Morgan. Goldman Sachs downgraded the shares of SBS in report on Friday, May 18 to “Neutral” rating. The firm earned “Neutral” rating on Monday, March 12 by Janney Capital. The company was downgraded on Tuesday, February 21 by Citigroup. The company was downgraded on Wednesday, April 4 by J.P. Morgan.
Cullen Capital Management Llc, which manages about $3.87B and $2.82B US Long portfolio, decreased its stake in Japan Tobacco Inc. (JAPAF) by 124,160 shares to 51,300 shares, valued at $1.46 million in 2018Q1, according to the filing. It also reduced its holding in Vodafone Group Plc (Adr) (NASDAQ:VOD) by 14,820 shares in the quarter, leaving it with 161,731 shares, and cut its stake in Indo Tambangraya Megah Pt.
Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.